Clinical Trials for Biovica

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Biovica

Clinical Trials (3)

BettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast Cancer

65 participants

Started: Sep 25, 2024 · Completed: Sep 30, 2034

2 conditions2 sponsors1 location

Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing

55 participants

Started: Mar 7, 2022 · Completed: Sep 30, 2029

2 conditions2 sponsors1 location

Determinants of Resistance to Endocrine Therapy and a Cyclin-dependent Kinases 4 and 6 (CDK4/6) Inhibitor for HR+ MBC

PHASE2Active, not recruiting

45 participants

Started: Jul 20, 2018 · Completed: Nov 1, 2026

1 condition3 sponsors1 location